Presentation and follow up characteristics of 121 patients with chronic ulcerative colitis in Uruguay
Keywords:
ULCEROUS COLITIS, URUGUAYAbstract
Objective: to describe clinical and presentation characteristics of a cohort of patients with chronic ulcerative colitis (CUC).
Methods: a cohort of 121 patients was retrospective and prospectively analyzed. Diagnosis was determined in patients of urban and rural Uruguay from both public and private health centers between 1951 and 2003 and seen by the authors at least once before June 30, 2003. Clinical histories were used to record age of disease development, topography, severity, extra intestinal manifestations, surgery requirements and mortality.
Results: 53.7% were women and 46.3% men. Minimum age of disease development was 3 years and the maximum was 76, the median was 32. Compromise was: 18.8% rectum, 22.2% rectosigmoid, 19.8% left colitis and 38.5% pan colitis. Beginning of the disease was mild in 47.1%, moderate in 31.4% and severe in 18.2% (p=0,0001). Extra intestinal manifestations were seen in 7.4% and family history of CUC in 4.1%. Ten patients (8.3%) required surgery, with a median of 5.5 years from the beginning of the disease to the surgery, 70% due to a peak severity. Mean time of follow up was 10.5 years. Colon cancer was observed in three patients (2.5%).
Conclusions: this cohort showed low surgery requirement associated to a peak severity and was performed mainly during the first year of the disease, low incidence of cancer and mortality.
References
2) Niv Y, Abuksis G, Fraser GM. Epidemiology of ulcerative colitis in Israel: a survey of Israeli Kibbutz Settlements. Am J Gastroenterol 2000; 95(3): 693-8.
3) Gower-Rousseau C, Salomez Jl, Dupas Jl, Marti R, Nuttens Mc, Votte A, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut 1994; 35(10): 1433-8.
4) Ekbom A, Helmick C, Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991; 100(2): 350-8.
5) Jiang XL, Cui HF. An analisis of 10218 ulcerative colitis cases in China. World J Gastroenterol 2002; 8(1): 158-61.
6) Pongprasobchai S, Manatsathit S, Leelakusolvong S, Sattawatthamrong Y, Boonyapisit S. Ulcerative colitis in Thailand: a clinical study and long term follow-up. J Med Assoc Thai 2001; 84(9): 1281-8.
7) Saro-Gismera C, Riestra-Menéndez S, Sánchez-Fernández R, Milla-Crespo A, Lacort-Fernández M, Milla-Crespo A, et al. Epidemiology in inflammatory bowel disease in five areas of Asturias. Spain. An Med Interna 2003; 20(5): 232-8.
8) Sandler R, Eisen G. Epidemiology of inflammatory bowel disease. In: Kirsner J. Inflamatory bowel disease. 5th ed. Philadelphia: W.B. Saunders, 2000: 89-112.
9) Miner PB, Jr. Clinical features, course, laboratory findings and complications in ulcerative colitis. In: Kirsner J. Inflamatory bowel disease. 5th ed. Philadelphia: W.B. Saunders, 2000: 299-304.
10) Illescas L, García L, Faggioni F, Velasco L. Ulcerative colitis: a 52 years retrospective study. Rev Gastroenterol Perú 1999; 19(2): 116-23.
11) Nos P, Arguello L, Hoyos M, Ramírez Jj, Hinojosa J, Moles Jr, et al. Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history. Rev Esp Enferm Dig 1996; 88(7): 470-4.
12) Ghayad E, Haddad F, El-Aam C, Tohme A, Nasr W. Inflammatory intestinal diseases and their extra-intestinal manifestations observed at Liban. J Med Liban 1997; 45(4): 191-6.
13) Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long term follow up of 1116 patients. Dig Dis Sci 1993; 38(6): 1137-46.
14) Henderiksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis based on results from a regional patient group from the country of Copenhagen. Gut 1985; 26(2): 158-63.
15) Picco MF, Bayless T. Prognostic considerations in idiopathic inflammatory bowel disease. In: Kirsner J. Inflammatory bowel disease. 5th ed. Philadelphia: W.B. Saunders, 2000: 765-80.
16) Legnani P, Kornbluth A. Clinical Features, Course, and Laboratory Findings in Ulcerative Colitis. In: Lichtenstein GR. The Clinician’s Guide to Inflammatory bowel diseases. Thorofare, New Jersey: Slack, 2003: 27-39.
17) Jewell DP. Ulcerative colitis. In: Feldman M, Scharschmidt BF, Sleisenger MH, Fordtran JS, eds. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. Philadelphia: W.B. Saunders, 1998: 1864-92.
18) Ahnen DJ. Gastrointestinal Malignances in Inflammatory bowel diseases. In: Kirsner J. Inflammatory bowel disease. 5th ed. Philadelphia: W.B. Saunders, 2000: 379-96.
19) Lashner BA. Cancer in Inflammatory Bowel Disease. In: Lichtenstein G. R. The Clinician’s Guide to Inflammatory bowel diseases. Thorofare, New Jersey: Slack, 2003: 113-23.
20) Harpaz N, Talbot IC. Colorectal cancer in idiopatic inflammatory bowel disease. Semin Diagn Pathol 1996; 13(4): 339-57.
21) Persson PG, Bernell O, Leijonmarck CE, Farahmand BY, Hellers G, Ahlbom A. Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Alimentary tract. Gastroenterology 1996; 110(5): 1339-45.
22) Farrokhyar F, Swarbrick ET, Grace RH, Hellier MD, Gent AE, Irvine EJ. Low mortality in ulcerative colitis and Crohn’s disease in three regional centers in England. Am J Gastroenterol 2001; 96(2): 501-7.
23) Loftus EV, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted country, Minesota, 1940-1993: incidence, prevalence, and survival. Gut 2000; 46(3): 336-43.
24) Delco F, Sonnenberg A. Commonalities in the time trends of Crohn´s disease and ulcerative colitis. Am J Gastroenterol 1999; 94(8): 2171-6.